TABLE 2.
Results of univariate and multivariate analyses of factors affecting weight loss ≥ 5%.
| Univariate analysis | |||
| Variables | OR (95% CI) | P-value | |
| Age at admission | <5 years old vs. ≥5 years old | 1.125 (0.459–2.758) | 0.797 |
| Sex | Female vs. Male | 1.684 (0.679–4.180) | 0.261 |
| Diagnosis | Non-malignant diseases vs. Malignant diseases | 0.615 (0.253–1.499) | 0.285 |
| Donor status | Unrelated vs. Related | 3.125 (1.221–8.00) | 0.018 |
| Conditioning chemotherapy | Reduced intensity vs. Myeloablative | 0.766 (0.286–2.055) | 0.597 |
| BMI at admission | Underweight vs. Average weight or Overweight | 0.394 (0.074–2.085) | 0.273 |
| Oral mucositis | Positive vs. Negative | 3.273 (1.266–8.458) | 0.014 |
| SCAN at admission | Scores ≥ 3 vs. Scores < 3 | 6.000 (1.908–18.867) | 0.002 |
| aGVHD | II-IV vs. 0-I | 11.562 (4.009–33.345) | <0.001 |
| Duration of corticosteroid | 1.032 (1.012–1.052) | 0.001 | |
| Multivariate analysis | |||
| SCAN at admission | Scores ≥ 3 vs. Scores < 3 | 4.474 (1.215–16.472) | 0.024 |
| aGVHD | II-IV vs. 0-I | 9.915 (3.302–29.771) | <0.001 |
Duration of corticosteroid is linear categories. SCAN, nutrition screening tool for childhood cancer; Grade II-IV aGVHD, moderate and severe acute graft versus host disease; and Grade 0-I aGVHD, none and mild acute graft versus host disease.